Literature DB >> 27366228

Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis.

Claire Zar-Kessler1, Amel Karaa2, Katherine Bustin Sims3, Virginia Clarke3, Braden Kuo4.   

Abstract

Fabry disease is a rare X-linked lysosomal storage disease characterized by the dysfunction of multiple systems, including significant gastrointestinal involvement such as diarrhea, abdominal pain, early satiety and nausea. The gastrointestinal symptoms of Fabry disease are thought to be due to neuropathic and myopathic changes leading to symptoms of dysmotility that are encountered in many other disorders. The gastrointestinal symptoms can often be one of the presenting signs of the disease in childhood, but can be misdiagnosed by gastroenterologists for many years due to their nonspecific presentation. As the chief treatment for Fabry is enzyme-replacement therapy that has been shown to stabilize and possibly reverse disease course, recognition of these symptoms and early diagnosis in an attempt to prevent progression with treatment, is critical.

Entities:  

Keywords:  abdominal pain; diarrhea; lysosomal storage disease; neuropathy

Year:  2016        PMID: 27366228      PMCID: PMC4913334          DOI: 10.1177/1756283X16642936

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  44 in total

1.  Gastrointestinal symptoms and delayed gastric emptying in Fabry's disease: response to metoclopramide.

Authors:  C E Argoff; N W Barton; R O Brady; H A Ziessman
Journal:  Nucl Med Commun       Date:  1998-09       Impact factor: 1.690

Review 2.  Histologic abnormalities of placental tissues in Fabry disease: a case report and review of the literature.

Authors:  Beth L Thurberg; Juan M Politei
Journal:  Hum Pathol       Date:  2011-11-10       Impact factor: 3.466

3.  Misdiagnosis in Fabry disease.

Authors:  Cintia L Marchesoni; Norma Roa; Ana María Pardal; Pablo Neumann; Guillermo Cáceres; Pablo Martínez; Isaac Kisinovsky; Silvia Bianchi; Ana Lía Tarabuso; Ricardo C Reisin
Journal:  J Pediatr       Date:  2010-05       Impact factor: 4.406

4.  Glycolipid storage material in Fabry's disease: a study by electron microscopy, freeze-fracture, and digital image analysis.

Authors:  M Simon; H Frey; H Gruler; B Bültmann
Journal:  J Struct Biol       Date:  1990-03       Impact factor: 2.867

5.  Gastrointestinal structure and function in Fabry's disease.

Authors:  K J Sheth; S L Werlin; M E Freeman; A E Hodach
Journal:  Am J Gastroenterol       Date:  1981-09       Impact factor: 10.864

6.  Anemia is a new complication in Fabry disease: data from the Fabry Outcome Survey.

Authors:  Julia Kleinert; François Dehout; Andreas Schwarting; Abelardo García de Lorenzo; Roberta Ricci; Christoph Kampmann; Michael Beck; Uma Ramaswami; Ales Linhart; Andreas Gal; Gunnar Houge; Urs Widmer; Atul Mehta; Gere Sunder-Plassmann
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

7.  Arterial remodelling in Fabry disease.

Authors:  P Boutouyrie; S Laurent; B Laloux; O Lidove; J P Grunfeld; D P Germain
Journal:  Acta Paediatr Suppl       Date:  2002

8.  Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy.

Authors:  Carmen Valbuena; Elísio Carvalho; Manuela Bustorff; Mariana Ganhão; Sandra Relvas; Rosete Nogueira; Fátima Carneiro; João Paulo Oliveira
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

Review 9.  [Fabry's disease: diagnosis in the pediatric age group].

Authors:  G Pintos Morell
Journal:  An Esp Pediatr       Date:  2002-07

10.  Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.

Authors:  Mehdi Namdar; Catherine Gebhard; Rafael Studiger; Yi Shi; Pavani Mocharla; Christian Schmied; Pedro Brugada; Thomas F Lüscher; Giovanni G Camici
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

View more
  9 in total

1.  Improvement of gastrointestinal symptoms in a significant proportion of male patients with classic Fabry disease treated with agalsidase beta: A Fabry Registry analysis stratified by phenotype.

Authors:  Robert J Hopkin; Ulla Feldt-Rasmussen; Dominique P Germain; Ana Jovanovic; Ana Maria Martins; Kathleen Nicholls; Alberto Ortiz; Juan Politei; Elvira Ponce; Carmen Varas; Frank Weidemann; Meng Yang; William R Wilcox
Journal:  Mol Genet Metab Rep       Date:  2020-10-30

2.  Clinical-Pathological Conference Series from the Medical University of Graz : Case No 153: A 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome.

Authors:  Elisabeth Fabian; Dietmar Schiller; Hermann Toplak; Michaela Brunner-Krainz; Franz Fazekas; Rainer Schoefl; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2017-11-21       Impact factor: 1.704

3.  Pathologic substrate of gastropathy in Anderson-Fabry disease.

Authors:  Alessandro Di Toro; Nupoor Narula; Lorenzo Giuliani; Monica Concardi; Alexandra Smirnova; Valentina Favalli; Mario Urtis; Costanza Alvisi; Elena Antoniazzi; Eloisa Arbustini
Journal:  Orphanet J Rare Dis       Date:  2020-06-22       Impact factor: 4.123

Review 4.  Fabry disease - a multisystemic disease with gastrointestinal manifestations.

Authors:  Malte Lenders; Eva Brand
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 5.  Histopathology of intestinal villi in neonatal and paediatric age: main features with clinical correlation - Part I.

Authors:  Chiara Rossi; Gloria Simoncelli; Giovanni Arpa; Alessandra Stracuzzi; Paola Parente; Matteo Fassan; Alessandro Vanoli; Vincenzo Villanacci
Journal:  Pathologica       Date:  2021-12-02

Review 6.  Metabolic Fingerprinting of Fabry Disease: Diagnostic and Prognostic Aspects.

Authors:  Maria Teresa Rocchetti; Federica Spadaccino; Valeria Catalano; Gianluigi Zaza; Giovanni Stallone; Daniela Fiocco; Giuseppe Stefano Netti; Elena Ranieri
Journal:  Metabolites       Date:  2022-07-28

7.  Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.

Authors:  E R Smith; I Ruderman; S Bruell; K M Nicholls; T D Hewitson; A S Talbot; S G Holt
Journal:  Osteoporos Int       Date:  2022-05-16       Impact factor: 5.071

Review 8.  Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review.

Authors:  Fabio Caputo; Lisa Lungaro; Adriana Galdi; Eleonora Zoli; Fiorella Giancola; Giacomo Caio; Roberto De Giorgio; Giorgio Zoli
Journal:  Int J Environ Res Public Health       Date:  2021-03-23       Impact factor: 3.390

9.  FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument.

Authors:  Alan L Shields; Roger E Lamoureux; Fiona Taylor; Jay A Barth; Andrew E Mulberg; Vivian Kessler; Nina Skuban
Journal:  Qual Life Res       Date:  2021-04-29       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.